Product Image

D3 + K2 Gummies Natural Raspberry Flavor

4.6
★ ★ ★ ★ ★
(78 ratings)
Vitamin K 120 mcg
Product Image
Score82

Two K2 forms and D3 make a coherent gummy, though high vitamin D and added carbohydrate reduce routine-use appeal.

How scoring works
Gummy
Quantity:60 Gummy(ies) • (30 servings)
Goals:
General Health
Heart Health
Cardiovascular Support
Anti-Aging
Bone Health

Score 82

Two K2 forms and D3 make a coherent gummy, though high vitamin D and added carbohydrate reduce routine-use appeal.

How scoring works
$12.99($0.43 per serving)
Walmart
$ 12.99
Pure Formulas
$ 12.99
Vitacost
$ 12.99
Report prices

Analysis

Vitamin D3 supports calcium absorption, while MK-4 and MK-7 cover two vitamin K2 forms with different persistence in the body. The combination has clear bone and calcium-handling logic.

The gummy format may help people who dislike pills, but it brings carbohydrates that a capsule would avoid. Vitamin D is supplied at a high amount rather than a basic maintenance level.

The formula needs a defined reason for high-dose vitamin D and should not be stacked casually with other D products. Both K2 forms also require careful management with warfarin or related medicines.

Who is it for
  • Adults who cannot swallow capsules
  • People specifically seeking MK-4 plus MK-7
  • Users with a defined need for high-dose vitamin D
Best for
  • Gummy D3 and K2 use
  • Combined MK-4 and MK-7 intake
  • Bone-support routines under guidance

Pros

  • Includes MK-4 and MK-7
  • Cholecalciferol vitamin D3
  • Easy raspberry gummy
  • Focused active formula

Cons

  • High vitamin D amount
  • Carbohydrate-containing gummy
  • Shorter package supply
  • No calcium or magnesium

Warnings

  • Vitamin K can oppose warfarin and related vitamin-K-antagonist medicines.
  • High-dose vitamin D should not be combined with other D supplements without checking total intake.
  • The gummy carbohydrate should be counted by people following medically restricted carbohydrate plans.

Nutrient quality

80 Highest impact

The active ingredients closely match the formula’s intended calcium-support role. The high vitamin D amount is aggressive for routine unsupervised maintenance.

Ingredient transparency

89 Highest impact

All listed active ingredients have specific amounts. The serving count is supplied, but complete use guidance is missing.

Customer satisfaction

78 High impact

The aggregate customer rating is solid but less compelling than leading peers. The modest review count limits confidence in the aggregate rating.

Value for money

78 High impact

The formula quality broadly supports its value, with a notable dosing or disclosure trade-off. Most additions have a practical role, though some format costs add little nutritional value.

Report analysis

Goals

General Health
General Health
Impact
Highest effect
A Goal FitA- Strength of SupportB- CoverageA Formula Quality
Vitamin D · 125 mcgVitamin K · 120 mcg

Vitamin D3 and both major vitamin K2 forms create a complementary plan for calcium handling, bone health, and immune support. The MK-7 amount is useful for focused daily supplementation.

The vitamin D3 amount exceeds the usual adult daily upper limit, while the gummy lacks a disclosed lipid carrier. Long-term use of 125 mcg vitamin D3 should be guided by vitamin D and calcium testing, especially in people with kidney or calcium disorders.

Study evidence
Vitamin D Supportive 115 studies
Vitamin K Supportive 34 studies
Heart Health
Heart Health
Impact
Highest effect
B Goal FitA Strength of SupportC CoverageA Formula Quality
Vitamin K · 120 mcgVitamin D · 125 mcg

MK-7 and MK-4 pair with vitamin D3 to support normal calcium handling in bones and blood vessels. The combination is relevant and coherent, though it does not cover lipid, nitric-oxide, or cardiac-energy pathways.

The K2 subtype and amount are clearly disclosed, while the vitamin D3 amount is high for routine unsupervised use. Vitamin K can interfere with warfarin and other vitamin K antagonists, and long-term high-dose vitamin D use should reflect individual needs.

Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
B+ Goal FitA Strength of SupportC- CoverageA Formula Quality
Vitamin K · 120 mcgVitamin D · 125 mcg

Vitamin D3 paired with K2 as both MK-4 and MK-7 provides a coherent calcium-management strategy. The 120 mcg MK-7 amount is clinically relevant, while the gummy format adds carbohydrate and lacks clear lipid support.

The formula is focused on one arterial-health pathway rather than broad cardiovascular coverage. Vitamin K2 can counteract warfarin and related vitamin-K-antagonist medicines, so users of those drugs need prescriber-guided intake consistency.

Study evidence
Vitamin D Mixed 170 studies
Vitamin K Supportive 40 studies
Anti-Aging
Anti-Aging
Impact
High effect
B- Goal FitB+ Strength of SupportC- CoverageA+ Formula Quality
Vitamin K · 120 mcgVitamin D · 125 mcg

Vitamin D3 and two vitamin K2 forms create a coherent calcium-management formula for bone and arterial aging. The 120 mcg MK-7 amount is well aligned with targeted use.

The 125 mcg vitamin D3 amount is high for routine unsupervised use, and the carbohydrate-heavy gummy provides no stated lipid carrier. People using warfarin should keep vitamin K intake consistent, while those with high calcium levels or other vitamin D sources should account for the total vitamin D load.

Study evidence
Vitamin D Supportive 50 studies
Vitamin K Supportive 27 studies
Bone Health
Bone Health
Impact
High effect
B Goal FitB Strength of SupportC- CoverageB+ Formula Quality
Vitamin K · 120 mcgVitamin D · 125 mcg

Vitamin K provides a clear and meaningful foundation for bone support. The main relevant amounts appear substantial enough to contribute in practice.

Coverage is concentrated on vitamin-guided mineral handling. The focused design leaves other major bone pathways uncovered.

Study evidence
Vitamin K Supportive 78 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Carbohydrates
5 Gram(s)
Sodium
10 mg
Vitamin D3 (Cholecalciferol)
 125 mcg
Vitamin K (Menaquinone-4, Menaquinone-7)
 120 mcg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Vitamin K (Menaquinone-4, Menaquinone-7) · 120 mcg OverallScore81
C Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyB+ Value

The formula includes MK-7 alongside MK-4, so it contains the preferred vitamin K2 subtype. The 120 mcg MK-7 serving lies within the preferred clinical range. The high-carbohydrate gummy lacks lipid support for absorption, while the clinical MK-7 serving provides good mid-tier value.

View ingredientView products
Loading alternative details
86 Performance

Liquid D-3 & MK-7

NOW
<p>Liquid delivery combines MK-7 with a substantial vitamin D3 amount and provides flexible dosing with strong bone- and heart-goal alignment. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
87 Performance

Vitamin D3 25 mcg (1000 IU) & K2 120 mcg

Natural Factors
<p>Moderate vitamin D3 and MK-7 create a balanced maintenance pairing in a softgel, with only minor ambiguity from duplicate K2 source entries. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
84 Performance

D3 + K2

Nature Made
<p>All-trans MK-7 and vitamin D3 use clearly defined forms in a focused softgel, improving active-form clarity. Vitamin D intake from other sources still matters, especially for the higher-dose options. Vitamin K requires clinician-directed consistency with warfarin-type medicines.</p>
88 Budget

Vitamin K2 MK-7 100 mcg

Nutricost
<p>At a lower serving cost, a clearly stated MK-7 amount creates a simple, easy-to-assess vitamin K2 option, although the dry capsule has no stated lipid carrier. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
87 Budget

MK-7 Vitamin K-2 100 mcg

NOW
<p>At a lower serving cost, a meaningful long-acting MK-7 amount provides focused vitamin K2 support with a simple active formula. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
85 Budget

Vitamin K2 MenaQ7 100 mcg

AN Amazing Nutrition Amazing Formulas
<p>At a lower serving cost, natto-derived MenaQ7 provides a clearly identified long-acting vitamin K2 form in a focused formula. It omits the original vitamin D3, so total vitamin D needs separate consideration. Vitamin K can oppose warfarin-type anticoagulants.</p>
86 Value

Vitamin K2 100 mcg + Vitamin D3 125 mcg

Nutricost
<p>MK-7 and vitamin D3 provide a fully disclosed combination at very favorable serving value, but the vitamin D amount is concentrated. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
86 Value

Vitamins D3 2500 IU (62.5 mcg) & K2 120 mcg

NaturesPlus
<p>MK-7 and a substantial vitamin D3 amount provide focused bone and cardiovascular support at a low serving cost, though the dry tablet lacks a lipid carrier. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
86 Value

Natural Vitamin K2 MK-7 with MenaQ7 100 mcg

Doctor's Best
<p>Branded MenaQ7 provides a meaningful long-acting K2 amount with clear active disclosure and good serving value. The combination remains close to the original purpose, while total vitamin D intake should guide selection. Vitamin K can reduce the effect of warfarin-type anticoagulants.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  3. Joint association of serum 25-hydroxyvitamin D concentration and body mass index on the acceleration of clinical biomarker-based biological aging.
    Pan Z; Zeng J; Chen Z; Chen S; Yang J; Li H; Wang S; Wang J; Li N; Gong Y; Liu M; Li C · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Cohort study389,217 participantsAnti-Aging forVitamin D
  4. Serum 25-Hydroxyvitamin D Levels as an Aging Marker: Strong Associations With Age and All-Cause Mortality Independent From Telomere Length, Epigenetic Age Acceleration, and 8-Isoprostane Levels.
    Schöttker B; Hagen L; Zhang Y; Gào X; Holleczek B; Gao X; Brenner H · The journals of gerontology. Series A, Biological sciences and medical sciences · 2019
    Cohort study9,940 participantsAnti-Aging forVitamin D
  5. Sex-specific associations of serum 25-hydroxyvitamin D concentrations with incident sarcopenia in older adults: A 2-year follow-up study.
    Song S; Lim JY; Kim M; Won CW; Park HY · The journal of nutrition, health & aging · 2025
    Cohort study1,292 participantsAnti-Aging forVitamin D
  6. Vitamin D deficit is associated with accelerated brain aging in the general population.
    Terock J; Bonk S; Frenzel S; Wittfeld K; Garvert L; Hosten N; Nauck M; Völzke H; Van der Auwera S; Grabe HJ · Psychiatry research. Neuroimaging · 2022
    Cross-sectional study1,865 participantsAnti-Aging forVitamin D
  7. Vitamin D intake is associated with dementia risk in the Washington Heights-Inwood Columbia Aging Project (WHICAP).
    Zhao C; Tsapanou A; Manly J; Schupf N; Brickman AM; Gu Y · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Cohort study1,759 participantsAnti-Aging forVitamin D
  8. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  9. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  10. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  11. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  12. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  13. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  14. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  15. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  16. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  17. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support Heart Health forVitamin D
  18. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
    Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V · Journal of the American Society of Nephrology : JASN · 2017
    Randomized trial120 participantsCardiovascular Support forVitamin D
  19. Randomized, placebo-controlled, double-blind clinical trial on the contributions of vitamin D in the control of cardiovascular risk factors, depressive symptoms and suicide risk.
    Porto C; Petribu K; Barbosa N; Magalhães R; Lira C; Porto AB; Markman-Filho B; Lordsleem A; Calado E; Magalhães J; Sougey E; Silva T; Junio A; Bandeira F; Leão R · American heart journal plus : cardiology research and practice · 2025
    Randomized trial224 participantsCardiovascular Support forVitamin D
  20. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial.
    Raed A; Bhagatwala J; Zhu H; Pollock NK; Parikh SJ; Huang Y; Havens R; Kotak I; Guo DH; Dong Y · PloS one · 2017
    Randomized trial70 participantsCardiovascular Support forVitamin D
  21. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsCardiovascular Support Heart Health forVitamin D
  22. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  23. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  24. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  25. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  26. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  27. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C · The Cochrane database of systematic reviews · 2014
    Meta-analysis95,286 participants159 studies pooledGeneral Health forVitamin D
  28. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A · Neurogastroenterology and motility · 2018
    Randomized trial90 participantsGeneral Health forVitamin D
  29. The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS; Wong Z; Thiruchelvam K · Inflammopharmacology · 2024
    Meta-analysis2,495 participants19 studies pooledGeneral Health forVitamin D
  30. Vitamin D Status and Mortality: A Systematic Review of Observational Studies.
    Heath AK; Kim IY; Hodge AM; English DR; Muller DC · International journal of environmental research and public health · 2019
    Systematic review84 studies pooledGeneral Health forVitamin D
  31. Meta-analysis of long-term vitamin D supplementation on overall mortality.
    Zheng Y; Zhu J; Zhou M; Cui L; Yao W; Liu Y · PloS one · 2014
    Meta-analysis42 studies pooledGeneral Health forVitamin D
  32. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  33. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  34. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  35. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  36. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  37. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  38. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  39. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K